These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3006383)

  • 41. Factors influencing survival in infiltrating lobular carcinoma of the breast.
    Sariego J; Byrd M; Kerstein M; Matsumoto T
    Am Surg; 1993 Jul; 59(7):405-9. PubMed ID: 8391768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer. Dare to do less.
    Marshall E
    Science; 2014 Mar; 343(6178):1454-6. PubMed ID: 24675949
    [No Abstract]   [Full Text] [Related]  

  • 43. [Causes of attenuation of the sound waves in neoplasms of the breast. Histologic and echographic correlation study].
    Gozzi G; Cressa C; Bazzocchi M; Stanta G; Vidali C
    Radiol Med; 1986 Apr; 72(4):195-8. PubMed ID: 3012661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staging and surgical approaches to carcinoma of the breast.
    Smith TJ
    Curr Opin Oncol; 1989 Dec; 1(2):295-301. PubMed ID: 2562286
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinico-morphological parallels in different histological variants of breast cancer].
    Belikov GN
    Khirurgiia (Mosk); 1983 Nov; (11):48-52. PubMed ID: 6319796
    [No Abstract]   [Full Text] [Related]  

  • 46. Perspectives on preoperative staging with breast MRI.
    Hollingsworth AB
    J Am Coll Surg; 2004 Jul; 199(1):173-4. PubMed ID: 15217651
    [No Abstract]   [Full Text] [Related]  

  • 47. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intraductal, lipid forming histiocytoid breast cancer. Contribution to the differential diagnosis of intraductal lipophage proliferations].
    Jäger J; Bässler R
    Pathologe; 1991 Jan; 12(1):44-7. PubMed ID: 1850829
    [No Abstract]   [Full Text] [Related]  

  • 50. [Case of breast cancer with esophageal metastasis causing dysphagia].
    Honma M; Kubota Y; Matsumoto M
    Gan No Rinsho; 1972 Jun; 18(6):419-22. PubMed ID: 4339537
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pituitary insufficiency as a presenting symptom of carcinoma of the breast].
    Scharf J; Nahir AM; Lichtig H; Plavnic J; Hemell S; Weinstock M; Eidelman S
    Harefuah; 1971 Nov; 81(9):443-4. PubMed ID: 4335039
    [No Abstract]   [Full Text] [Related]  

  • 52. Lobular carcinoma in situ and intraductal carcinoma of the breast.
    Rosen PP
    Monogr Pathol; 1984; (25):59-105. PubMed ID: 6330539
    [No Abstract]   [Full Text] [Related]  

  • 53. [Significance of ultrastructural characteristics of cell surface in the evaluation of the degree of malignancy of breast cancer].
    Domagała W; Kotańska K
    Patol Pol; 1983; 34(3):249-56. PubMed ID: 6326032
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
    Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Stromal reaction in breast cancer].
    Caselitz J; Stegner HE; Spiegel A
    Verh Dtsch Ges Pathol; 1985; 69():254-7. PubMed ID: 3006379
    [No Abstract]   [Full Text] [Related]  

  • 56. [Breast cancer with late recurrence. A preliminary report].
    Hartveit F; Wiig J
    Nord Med; 1971 Jun; 85(24):748-50. PubMed ID: 4326356
    [No Abstract]   [Full Text] [Related]  

  • 57. Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.
    Amat S; Penault-Llorca F; Cure H; Le Bouedëc G; Achard JL; Van Praagh I; Feillel V; Mouret-Reynier MA; Dauplat J; Chollet P
    Int J Oncol; 2002 Apr; 20(4):791-6. PubMed ID: 11894126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Breast cancer in a man treated with diethylstilbestrol.
    O'Grady WP; McDivitt RW
    Arch Pathol; 1969 Aug; 88(2):162-5. PubMed ID: 4307436
    [No Abstract]   [Full Text] [Related]  

  • 59. Recurrence of breast cancer. A retrospective study of 569 cases in clinical stages I-III.
    Nikkanen TA
    Acta Chir Scand; 1981; 147(4):239-45. PubMed ID: 6275648
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of breast magnetic resonance imaging in ductal carcinoma in situ.
    Harms SE
    Breast J; 2005; 11(6):379-81. PubMed ID: 16297079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.